Cosmetics testing kills 3.9 million animals
India | Opinion | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2012
As cosmetics grow more sophisticated and the line between cosmetic products and drugs continues to blu...Read more
Asia Pacific pharma meet at Hyderabad in September
India | News | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2012
Bangalore: Hyderabad will host an Asia Pacific International Pharma Business Meet between September 26 and 28, 2012. The...Read more
Mylan gets India's nod for $1.6 bn Agila takeover
India | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2013
New Delhi: India has cleared US-based Mylan's $1.6 billion takeover plan of India-based Agila Specialties even as the co...Read more
International consortium sequences tomato genome
India | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the g...Read more
Indian court: HP govt should regulate drug prices
India | News | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2013
New Delhi: India's Himachal Pradesh High Court has asked the state government to establish a committee of experts in ord...Read more
Wockhardt chairman: Painkiller ban may cost us $100 mn
India | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2013
Singapore: The several bans on Proxyvon, a brand under India-based Wockhardt sold formulation of the painkiller dextropr...Read more
Cadila to start manufacturing facility in Russia
India | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Indian pharmaceutical major, Cadila Pharmaceutical is getting closer to constructing a modern manufacturing f...Read more
Indian nutraceuticals market to double in next 5 years
India | News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2013
Singapore: A latest research report filed by Ikon Marketing Consultants revealed that the Indian domestic nutraceutical ...Read more
India firm gets US nod to market image-guided oncology device
India | Regulatory | By BioSpectrum Bureau | 1 Comment | 27 May, 2014
Singapore: India based Perfint Healthcare, solution provider for image guided interventional procedures in oncology and ...Read more
Medical laser market to reach $8.8 bn by 2018: GIA
India | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2013
Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, ...Read more
Jubilant's Spironolactone receives ANDA approval
India | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2014
Singapore: Jubilant Life Sciences, an integrated Pharmaceuticals and Life Sciences Company announced that it has receive...Read more
US FDA approves acne medication Absorica
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 28 May, 2012
New Delhi: The US Food and Drug Administration (FDA) has approved Absorica, a novel, patented brand formulation of the a...Read more
Novo's insulin injection Tresiba to be launched in India
India | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: Novo Nordisk is all set to launch a new basal insulin for adult patients with type 1 and type 2 diabetes, Tre...Read more
India's budget boost for biotech research
India | Analysis | By Rahul Koul Koul | 0 Comment | 11 Jul, 2014
India: With a thrust on technology development through public private partnerships, the union budget 2014 offers big enc...Read more
UCB sues 15 firms for patent infringement
India | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013
Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...Read more
India | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pa...Read more
Phase III trial of $1 vaccine RotaVac completed
India | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the...Read more
Diabetes drug Actos banned in India
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...Read more